Kikuchi, Taku https://orcid.org/0000-0002-3210-7756
Tsukada, Nobuhiro
Kunisada, Kodai
Nomura-Yogo, Moe
Oda, Yuki
Sato, Kota
Takei, Tomomi
Ogura, Mizuki
Abe, Yu
Suzuki, Kenshi
Ishida, Tadao
Article History
Received: 2 January 2024
Revised: 1 April 2024
Accepted: 4 April 2024
First Online: 19 April 2024
Declarations
:
: TK received personal fees from Janssen, Takeda, and Sanofi. NT received personal fees from Janssen and Sanofi. TI received honoraria from Ono, Takeda, Celgene/Bristol-Myers Squibb, and Janssen. KS received honoraria from Takeda, Celgene, Ono, Amgen, Novartis, Sanofi, BMS, AbbVie, and Janssen; consultancy fees from Takeda, Amgen, Janssen, and Celgene; and research funding from BMS, Celgene, and Amgen. The other authors declare no competing financial interests.
: This study was approved by the Institutional Review Board of the JRCMC and conducted under an abbreviated informed consent procedure and an opt-out consent principle. None of the participants requested exclusion from the study. The study was conducted in accordance with the Declaration of Helsinki.